Table 1.
Gene (chromosomal locus studies) | Function | Prevalence in IBD-related CRC | Timing in the dysplasia–cancer sequence | Pathogenesis or mechanisms of mutation | References |
---|---|---|---|---|---|
APC (5q21) | Tumor suppressor gene (cell adhesion) | Rare (<15%) | Late | HGD, CRC | Greewald et al. [191], Kern et al. [192], Tarmin et al. [193], Redston et al. [194], Willenbucher et al. [195], Tomlinson et al. [200], Willenbucher et al. [234], Umetani et al. [196], Aust et al. [197], Aust et al. [198], Aust et al. [199], Maia et al. [235] |
DCC/DPC (18Q21) | Tumor suppressor gene (cell adhesion) | Common (>50%0 | Early | Dysplasia | Lei et al. [201], Willenbucher et al. [195], Hoque et al. [202], Tomlinson et al. [200], Willenbucher et al. [234], Aust et al. [197] |
TP53 (17p13) | Tumor suppressor gene (cell cycle, apoptosis) | Common (>50%) | Early | May precede dysplasia | Burmer et al. [203], Greewald et al. [191], Yin et al. [204], Harpaz N et al. [205], Brentnall et al. [206], Chaubert et al. [207], Klump et al. [208], Holzman et al. [209], Rabinovitch et al. [210], Aust et al. [197], Wong et al. [211], Hussain et al. [212], Maia et al. [235], Nathanson et al. [213] |
CDKN2A (9P21) | Tumor suppressor gene (cell cycle inhibitor) | Frequent | Early | Hypermethylation | Hsieh et al. [214], Issa et al. [215] |
CDKN2A (9P21) | Tumor suppressor gene (indirect p53 regulator) | Frequent | Early | Hypermethylation | Sato et al. [216], Moriyama et al. [217] |
CDKN2A (12p13) | Tumor suppressor gene (cell cycle regulation) | Under-expressed in CRC | Walsh et al. [218] | ||
E-cadherin | Tumor suppressor gene (cell adhesion) | Frequent | Early | Hypermethylation | Ilyas et al. [219], Tomlinson et al. [200], Wheeler et al. [220], Azarschab et al. [221], Van Dekken et al. [222] |
K-ras (12p12) | Oncogene (cell cycle regulation) | Uncommon (<25%) | Late | HGD, CRC | Burmer et al. [223], Meltzer et al. [224], Bell et al. [225], Chaubert et al. [207], Redston et al. [194], Umetani et al. [196], Lyda et al. [226], Holzmann et al. [227], Aust et al. [228] |
C-src TGFβR2 RII |
Oncogene TGF-β1 receptor gene |
Intermediate MSI-related CRC (less common than sporadic MSI CRC) | Unknown Unknown |
LGD to HGD MSI |
Cartwright et al. [229], Souza et al. [230] |
MSH2 (2p22) | DNA mismatch repair gene | MSI-related CRC | Unknown | MSI | Brentnall et al. [231], Noffsinger et al. [232] |
MLH1 | DNA mismatch repair gene | Intermediate MSI-related CRC (less common than sporadic MSI CRC) | Unknown | MSI, hypermethylation | Fleisher et al. [233] |
Abbreviations: APC adenomatous polyposis coli, CRC colorectal carcinoma, DCC deleted in colon cancer, HGD high-grade dysplasia, LGD low-grade dysplasia, MSI microsatellite instability, TGF transforming growth factor